SPOTLIGHT Reuters Pharma 2025: Pre-Conference Talks Featuring Konrad DobschuetzByHimanshu SehgalApril 4, 20250Comments
News BridgeBio Oncology Therapeutics Reports the First Patient Dosing in P-I (KONQUER-101) Trial of BBO-11818 for Advanced Solid TumorsByRidhi RastogiApril 3, 20250Comments
News Accord Healthcare Reports the CHMP’s Positive Opinion on Osvyrti and Jubereq (Biosimilar, Prolia & Xgeva)ByRidhi RastogiApril 3, 20250Comments
News Siemens to Acquire Dotmatics for $5.1B, Strengthening its Position in Life Science MarketByRidhi RastogiApril 3, 20250Comments
News The US FDA Grants 510(k) Clearance to Medivis’ Spine Navigation PlatformByRidhi RastogiApril 3, 20250Comments
News SineuGene Therapeutics Reports the US FDA’s IND Clearance of SNUG01 for Amyotrophic Lateral SclerosisByRidhi RastogiApril 3, 20250Comments
News Novartis’ Vanrafia (Atrasentan) Receives the US FDA’s Accelerated Approval for Primary IgA Nephropathy (IgAN)ByDipanshu DixitApril 3, 20250Comments
News Sanofi Licenses an Undisclosed Nurix Therapeutics’ Drug Program for Autoimmune DiseasesByRidhi RastogiApril 3, 20250Comments
INSIGHTS+ Know Your Investor: Janus Henderson Group Plc (April’25 Edition)ByPrince GiriApril 3, 20250Comments
